TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Streamex ( (STEX) ) has provided an update.
On November 4, 2025, Streamex Corp., formerly known as BioSig Technologies, Inc., successfully concluded its special meeting of stockholders, approving the issuance of over 109 million shares of common stock and one share of Super Voting Preferred Stock as part of the acquisition of Streamex Exchange Corporation. This acquisition, initially proposed in May 2025, was finalized following stockholder approval, marking a significant step in the company’s strategic growth and positioning in the market.
The most recent analyst rating on (STEX) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Streamex stock, see the STEX Stock Forecast page.
Spark’s Take on STEX Stock
According to Spark, TipRanks’ AI Analyst, STEX is a Underperform.
BioSig Technologies faces significant financial difficulties, with persistent losses, high leverage, and negative cash flow trends. While technical analysis indicates some short-term momentum, potential overbought conditions warrant caution. The negative P/E ratio further underscores valuation challenges and risks associated with the stock.
To see Spark’s full report on STEX stock, click here.
More about Streamex
Average Trading Volume: 1,165,685
Technical Sentiment Signal: Hold
Current Market Cap: $167.2M
Find detailed analytics on STEX stock on TipRanks’ Stock Analysis page.